It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Rift Valley fever phlebovirus (RVFV, Phenuiviridae) is an emerging arbovirus that can cause potentially fatal disease in many host species including ruminants and humans. Thus, tools to detect this pathogen within tissue samples from routine diagnostic investigations or for research purposes are of major interest. This study compares the immunohistological usefulness of several mono- and polyclonal antibodies against RVFV epitopes in tissue samples derived from natural hosts of epidemiologic importance (sheep), potentially virus transmitting insect species (Culex quinquefasciatus, Aedes aegypti) as well as scientific infection models (mouse, Drosophila melanogaster, C6/36 cell pellet). While the nucleoprotein was the epitope most prominently detected in mammal and mosquito tissue samples, fruit fly tissues showed expression of glycoproteins only. Antibodies against non-structural proteins exhibited single cell reactions in salivary glands of mosquitoes and the C6/36 cell pellet. However, as single antibodies exhibited a cross reactivity of varying degree in non-infected specimens, a careful interpretation of positive reactions and consideration of adequate controls remains of critical importance. The results suggest that primary antibodies directed against viral nucleoproteins and glycoproteins can facilitate RVFV detection in mammals and insects, respectively, and therefore will allow RVFV detection for diagnostic and research purposes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Veterinary Medicine Hannover, Department of Pathology, Hannover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191)
2 Friedrich-Loeffler-Institute, Institute of Novel and Emerging Infectious Diseases, Greifswald, Germany (GRID:grid.412970.9)
3 University of Veterinary Medicine Hannover, Institute for Parasitology and Research Center for Emerging Infections and Zoonoses, Hannover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191)
4 Bernhard Nocht Institute for Tropical Medicine, Department of Arbovirology, Hamburg, Germany (GRID:grid.424065.1) (ISNI:0000 0001 0701 3136)
5 Friedrich-Loeffler-Institute, Institute of Novel and Emerging Infectious Diseases, Greifswald, Germany (GRID:grid.424065.1)
6 MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK (GRID:grid.301713.7) (ISNI:0000 0004 0393 3981)
7 Leipzig University, Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786)
8 Friedrich-Loeffler-Institute, Institute of Novel and Emerging Infectious Diseases, Greifswald, Germany (GRID:grid.412970.9); Leipzig University, Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786)
9 Friedrich-Loeffler-Institute, Institute of Novel and Emerging Infectious Diseases, Greifswald, Germany (GRID:grid.9647.c)